DK58387D0 - Farmaceutiske praeparatformer til stabilisering af interferon-alfa, deres anvendelse og fremgangsmaade til deres fremstilling - Google Patents

Farmaceutiske praeparatformer til stabilisering af interferon-alfa, deres anvendelse og fremgangsmaade til deres fremstilling

Info

Publication number
DK58387D0
DK58387D0 DK058387A DK58387A DK58387D0 DK 58387 D0 DK58387 D0 DK 58387D0 DK 058387 A DK058387 A DK 058387A DK 58387 A DK58387 A DK 58387A DK 58387 D0 DK58387 D0 DK 58387D0
Authority
DK
Denmark
Prior art keywords
alfa
interferon
stabilization
procedure
preparation
Prior art date
Application number
DK058387A
Other languages
English (en)
Other versions
DK164202C (da
DK58387A (da
DK164202B (da
Inventor
Helmut Franz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK58387D0 publication Critical patent/DK58387D0/da
Publication of DK58387A publication Critical patent/DK58387A/da
Publication of DK164202B publication Critical patent/DK164202B/da
Application granted granted Critical
Publication of DK164202C publication Critical patent/DK164202C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK058387A 1986-02-05 1987-02-04 Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling DK164202C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863603444 DE3603444A1 (de) 1986-02-05 1986-02-05 Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
DE3603444 1986-02-05

Publications (4)

Publication Number Publication Date
DK58387D0 true DK58387D0 (da) 1987-02-04
DK58387A DK58387A (da) 1987-08-06
DK164202B DK164202B (da) 1992-05-25
DK164202C DK164202C (da) 1992-10-19

Family

ID=6293372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK058387A DK164202C (da) 1986-02-05 1987-02-04 Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling

Country Status (20)

Country Link
EP (1) EP0231816B1 (da)
JP (1) JPS62209024A (da)
KR (1) KR870007698A (da)
AT (1) ATE63823T1 (da)
AU (1) AU601712B2 (da)
CA (1) CA1295242C (da)
DD (1) DD284602A5 (da)
DE (2) DE3603444A1 (da)
DK (1) DK164202C (da)
ES (1) ES2028796T3 (da)
FI (1) FI86144C (da)
GR (1) GR3002270T3 (da)
HU (1) HU196560B (da)
IE (1) IE59697B1 (da)
IL (1) IL81472A0 (da)
NO (1) NO169638C (da)
NZ (1) NZ219169A (da)
PH (1) PH24377A (da)
PT (1) PT84243B (da)
ZA (1) ZA87793B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275804A (en) * 1986-02-25 1994-01-04 E. B. Michaels Research Associates, Inc. Process and composition for oral hygiene
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3803312A1 (de) * 1988-02-04 1989-08-10 Gerd Prof Dr Med Gross Verwendung eines interferonenthaltenden gels
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
WO1989010756A1 (fr) * 1988-05-06 1989-11-16 Toray Industries, Inc. COMPOSITION D'INTERFERON beta STABLE
US5389676A (en) * 1991-03-22 1995-02-14 E. B. Michaels Research Associates, Inc. Viscous surfactant emulsion compositions
US5244652A (en) * 1991-03-22 1993-09-14 E. B. Michaels Research Associates, Inc. Viscous surface active composition
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
WO1993006856A1 (en) * 1991-10-11 1993-04-15 Mark Cedric Gillies Treating ophthalmic fibrosis using interferon-alpha
US6630168B1 (en) 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
FI106465B (fi) * 1998-06-10 2001-02-15 Suomen Punainen Risti Veripalv Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
US6923966B2 (en) 1999-04-08 2005-08-02 Schering Corporation Melanoma therapy
JP4536194B2 (ja) * 2000-02-17 2010-09-01 大日本住友製薬株式会社 安定な注射用製剤
ES2357474T3 (es) * 2000-03-07 2011-04-26 Rush-Presbyterian-St.Luke's Medical Center Composiciones y su uso para atrapar e inactivar microbios patógenos y espermatoziodes.
US6328987B1 (en) * 2000-11-03 2001-12-11 Jan Marini Skin Research, Inc. Cosmetic skin care compositions containing alpha interferon
EP1449540A4 (en) * 2001-11-02 2007-01-10 Sekisui Chemical Co Ltd CYTOKIN INDUCING MATERAIL AND CYTOKIN INDUCTIVE INSTRUMENT
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
MY188369A (en) * 2009-05-29 2021-12-06 Filligent Ltd Composition for use in decreasing the transmission of human pathogens
RU2431489C1 (ru) * 2010-05-25 2011-10-20 Федеральное государственное учреждение "Российский научный центр рентгенорадиологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "РНЦРР Росмедтехнологий") Способ лечения хронических воспалительных заболеваний толстого кишечника
CN104271142B (zh) * 2012-03-01 2017-07-04 福斯特斯特林研究公司 含有α连接蛋白C‑末端(ACT)肽的局部凝胶
JP6081156B2 (ja) * 2012-11-15 2017-02-15 アルケア株式会社 ハイドロゲル
DE102012222365A1 (de) 2012-12-05 2014-06-05 Aesculap Ag Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen
CA2913115A1 (en) * 2013-06-09 2014-12-18 Efranat Ltd. Compositions comprising gc-macrophage activating factor and uses thereof
WO2018143911A1 (en) 2017-01-31 2018-08-09 Kimberly-Clark Worldwide, Inc. Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same
MX2023004631A (es) 2020-10-22 2023-07-20 Xequel Bio Inc Formulaciones peptidicas y usos oftalmicos de las mismas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
EP0139286B1 (en) * 1983-10-14 1991-08-21 Sumitomo Pharmaceuticals Company, Limited Prolonged sustained-release preparations
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
JPS60260523A (ja) * 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd インタ−フエロンの凍結乾燥医薬組成物

Also Published As

Publication number Publication date
DK164202C (da) 1992-10-19
NO169638C (no) 1992-07-22
FI870457L (fi) 1987-08-06
IL81472A0 (en) 1987-09-16
FI870457A0 (fi) 1987-02-03
IE59697B1 (en) 1994-03-23
JPS62209024A (ja) 1987-09-14
KR870007698A (ko) 1987-09-21
GR3002270T3 (en) 1992-12-30
ZA87793B (en) 1988-10-26
DE3603444A1 (de) 1987-08-06
NZ219169A (en) 1990-04-26
NO169638B (no) 1992-04-13
AU601712B2 (en) 1990-09-20
PT84243B (pt) 1989-09-14
FI86144C (fi) 1992-07-27
DK58387A (da) 1987-08-06
EP0231816B1 (de) 1991-05-29
NO870441D0 (no) 1987-02-04
HU196560B (en) 1988-12-28
ES2028796T3 (es) 1992-07-16
HUT43494A (en) 1987-11-30
PT84243A (de) 1987-03-01
CA1295242C (en) 1992-02-04
EP0231816A3 (en) 1987-09-23
DD284602A5 (de) 1990-11-21
IE870295L (en) 1987-08-05
NO870441L (no) 1987-08-06
AU6829287A (en) 1987-08-06
ATE63823T1 (de) 1991-06-15
DE3770280D1 (de) 1991-07-04
DK164202B (da) 1992-05-25
PH24377A (en) 1990-06-13
FI86144B (fi) 1992-04-15
EP0231816A2 (de) 1987-08-12

Similar Documents

Publication Publication Date Title
DK58387D0 (da) Farmaceutiske praeparatformer til stabilisering af interferon-alfa, deres anvendelse og fremgangsmaade til deres fremstilling
DK203787A (da) Praeparat til nasal administrering
ES2009216A6 (es) Metodo de preparar un derivado de interleucina-lalfa.
NO883229D0 (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
DK131887D0 (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DK516288D0 (da) Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
FI853228A7 (fi) Uudet -butyrolaktaamit, niiden farmaseuttisesti aktiiviset koostumukset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkeaineina.
DK409786A (da) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-oner, fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler, pharmaceutiske praeparater og mellemprodukter
DK144885D0 (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK179786D0 (da) (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
IT8748235A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK238089A (da) Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK180086D0 (da) 12b-substituerede 1-hydroxymethyl-octahydroindolo(2,3-a)-quinolizinderivater eller isomere eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
NO940533D0 (no) Rensede streptograminer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
DK454588D0 (da) Substituerede thienoimidazolderivater, deres fremstilling, farmaceutiske praeparater deraf og deres anvendelse som mavesyresekretionshaemmende midler
ATE67674T1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
IT8520150A0 (it) Nuovi derivati ad attivita'terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
DK454185D0 (da) Aminosyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner
ES2135424T3 (es) Composicion oral a base de ibuprofeno.

Legal Events

Date Code Title Description
PBP Patent lapsed